Standout Papers
Immediate Impact
52 standout
Citing Papers
The emerging role of lactate in tumor microenvironment and its clinical relevance
2024 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Works of Guofan Qu being referenced
Anlotinib for metastasis soft tissue sarcoma: A randomized, double-blind, placebo-controlled and multi-centered clinical trial.
2018
Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Guofan Qu | 335 | 293 | 105 | 231 | 28 | 710 | |
| John Skarlatos | 334 | 234 | 95 | 182 | 20 | 815 | |
| Colby S. Shemesh | 141 | 345 | 34 | 170 | 33 | 841 | |
| Yi An | 162 | 211 | 245 | 146 | 47 | 753 | |
| Chongqi Tu | 294 | 162 | 185 | 133 | 57 | 711 | |
| Hannah C. Beird | 271 | 193 | 34 | 69 | 26 | 764 | |
| Edvard Zhavrid | 245 | 217 | 41 | 209 | 34 | 625 | |
| Marjory Koller | 193 | 165 | 205 | 280 | 16 | 665 | |
| Hui Tan | 180 | 117 | 96 | 202 | 45 | 847 | |
| Lukas Kraehenbuehl | 123 | 421 | 67 | 90 | 21 | 701 | |
| P L Choyke | 257 | 145 | 255 | 67 | 15 | 789 |
All Works
Login with ORCID to disown or claim papers
Loading papers...